{"database": "openregs", "table": "dockets", "rows": [["CPSC-2021-0027", "CPSC", "Petition to Exempt Baloxavir Marboxil (XOFLUZA\u2122) in 40 mg and 80 mg Tablet Doses from Special Packaging Requirements of the PPPA", "Rulemaking", "2024-04-19T11:51:37Z", "0b00006484d6ed5d"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["CPSC-2021-0027"], "units": {}, "query_ms": 0.3294271882623434, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}